Hardev Pandha

1.7k total citations
20 papers, 947 citations indexed

About

Hardev Pandha is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Hardev Pandha has authored 20 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Immunology. Recurrent topics in Hardev Pandha's work include Immunotherapy and Immune Responses (7 papers), Renal cell carcinoma treatment (5 papers) and Renal and related cancers (4 papers). Hardev Pandha is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Renal cell carcinoma treatment (5 papers) and Renal and related cancers (4 papers). Hardev Pandha collaborates with scholars based in United Kingdom, United States and Germany. Hardev Pandha's co-authors include Nicola Annels, Deborah Stocken, Gary Middleton, Justin C. St. John, Nicholas R. Lemoine, Anne Rigg, Graham Pawelec, Stephen Ward, Victoria Adams and Karin Hähnel and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Hardev Pandha

19 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hardev Pandha United Kingdom 9 608 506 282 117 108 20 947
Hiroshi Yamaguchi Japan 14 553 0.9× 664 1.3× 506 1.8× 114 1.0× 136 1.3× 20 1.1k
Gulidanna Shayan United States 10 808 1.3× 771 1.5× 218 0.8× 79 0.7× 109 1.0× 20 1.2k
Jessica Moskovitz United States 10 676 1.1× 732 1.4× 231 0.8× 65 0.6× 110 1.0× 13 1.1k
Kohjiro Mashino Japan 12 473 0.8× 521 1.0× 463 1.6× 93 0.8× 100 0.9× 20 948
Mihalis S. Kariolis United States 8 398 0.7× 326 0.6× 241 0.9× 96 0.8× 100 0.9× 10 692
Federico Sandoval France 9 594 1.0× 777 1.5× 306 1.1× 85 0.7× 147 1.4× 16 1.1k
Y Cho Japan 9 341 0.6× 490 1.0× 218 0.8× 107 0.9× 161 1.5× 15 842
Inka Zoernig Germany 16 625 1.0× 841 1.7× 151 0.5× 113 1.0× 120 1.1× 24 1.1k
Kaoru Onozato Japan 5 467 0.8× 570 1.1× 194 0.7× 93 0.8× 83 0.8× 5 864
Sara Michel Germany 14 464 0.8× 725 1.4× 221 0.8× 101 0.9× 202 1.9× 18 1.1k

Countries citing papers authored by Hardev Pandha

Since Specialization
Citations

This map shows the geographic impact of Hardev Pandha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hardev Pandha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hardev Pandha more than expected).

Fields of papers citing papers by Hardev Pandha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hardev Pandha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hardev Pandha. The network helps show where Hardev Pandha may publish in the future.

Co-authorship network of co-authors of Hardev Pandha

This figure shows the co-authorship network connecting the top 25 collaborators of Hardev Pandha. A scholar is included among the top collaborators of Hardev Pandha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hardev Pandha. Hardev Pandha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Isaac, Giorgis, Olivier Cexus, Hardev Pandha, et al.. (2022). High Throughput LC-MS Platform for Large Scale Screening of Bioactive Polar Lipids in Human Plasma and Serum. Journal of Proteome Research. 21(11). 2596–2608. 12 indexed citations
3.
Michael, Agnieszka, et al.. (2021). Adjuvant therapy for renal cell carcinoma. Journal of Cancer Metastasis and Treatment. 1 indexed citations
4.
Pandha, Hardev, Kevin J. Harrington, Alan Melcher, et al.. (2017). Abstract CT115: Phase 1b KEYNOTE 200 (STORM study): A study of an intravenously delivered oncolytic virus, Coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients. Cancer Research. 77(13_Supplement). CT115–CT115. 8 indexed citations
5.
Rogers, Wendy, Susan Short, Richard Morgan, & Hardev Pandha. (2016). P08.17 Targeting developmental proteins as a novel treatment in glioblastoma. Neuro-Oncology. 18(suppl_4). iv44–iv44. 1 indexed citations
6.
Crea, Francesco, Luca Quagliata, Agnieszka Michael, et al.. (2015). Integrated analysis of the prostate cancer small‐nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression. Molecular Oncology. 10(5). 693–703. 53 indexed citations
7.
Michael, Agnieszka, et al.. (2013). Prostate cancer vaccines. Expert Review of Vaccines. 12(3). 253–262. 7 indexed citations
8.
Tuan, Jeffrey, Hardev Pandha, Cathy Corbishley, & Vincent Khoo. (2012). Basaloid carcinoma of the prostate: A literature review with case report. Indian Journal of Urology. 28(3). 322–322. 6 indexed citations
9.
10.
11.
Derhovanessian, Evelyna, Victoria Adams, Karin Hähnel, et al.. (2009). Pretreatment frequency of circulating IL‐17+CD4+ T‐cells, but not Tregs, correlates with clinical response to whole‐cell vaccination in prostate cancer patients. International Journal of Cancer. 125(6). 1372–1379. 94 indexed citations
12.
Alamara, Christina, et al.. (2008). Renal oncocytoma: A case report and short review of the literature. European Journal of Internal Medicine. 19(7). e67–e69. 11 indexed citations
13.
Pandha, Hardev, et al.. (2008). Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond. Current Pharmaceutical Design. 14(22). 2229–2251. 7 indexed citations
14.
Morgan, Richard, et al.. (2008). IMMUNOREGULATORY EFFECTS OF CRYO-TREATED PROSTATE CANCER CELLS ON HUMAN DENDRITIC CELLS USING A NOVEL IN VITRO CRYOTHERAPY MODEL. The Journal of Urology. 179(4S). 48–48. 1 indexed citations
15.
Pandha, Hardev, Anne Rigg, Justin C. St. John, & Nicholas R. Lemoine. (2007). Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines. Clinical & Experimental Immunology. 148(1). 127–135. 81 indexed citations
16.
Ball, Graham, et al.. (2005). Delayed Disease Progression after Allogeneic Cell Vaccination in Hormone-Resistant Prostate Cancer and Correlation with Immunologic Variables. Clinical Cancer Research. 11(12). 4469–4478. 96 indexed citations
17.
Spicer, James, et al.. (2004). Cellular immunotherapy for cancer: current concepts and clinical perspectives. Clinical Oncology. 16(6). 395–404. 1 indexed citations
18.
Pandha, Hardev. (2004). Integrative Tumor Board: Metastatic Renal Cell Carcinoma. Integrative Cancer Therapies. 3(1). 29–34. 1 indexed citations
19.
John, Justin C. St., Hardev Pandha, & Angus Dalgleish. (2000). Detection of T Cell Cytokine Production as a Tool for Monitoring Immunotherapy. Disease Markers. 16(1-2). 71–75. 2 indexed citations
20.
Syrigos, Konstantinos N., Thomas Krausz, Jonathan Waxman, et al.. (1995). E‐cadherin expression in bladder cancer using formalin‐fixed, paraffin‐embedded tissues: Correlation with histopathological grade, tumour stage and survival. International Journal of Cancer. 64(6). 367–370. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroshi Yamaguchi Breakdown of academic impact, for papers by Gulidanna Shayan Breakdown of academic impact, for papers by Jessica Moskovitz Breakdown of academic impact, for papers by Kohjiro Mashino Breakdown of academic impact, for papers by Mihalis S. Kariolis Breakdown of academic impact, for papers by Federico Sandoval Breakdown of academic impact, for papers by Y Cho Breakdown of academic impact, for papers by Inka Zoernig Breakdown of academic impact, for papers by Kaoru Onozato Breakdown of academic impact, for papers by Sara Michel
Rankless by CCL
2026